Astec LifeSciences Limited has informed the Exchange regarding allotment of 577 securities pursuant to ESOP on February 24, 2026
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Nomination and Remuneration Committee of Astec LifeSciences approved the allotment of 577 equity shares to employees on February 24, 2026, upon exercise of stock options under the ESOP 2012 plan. Of these, 300 shares were issued at an exercise price of Rs. 34 per share (under the original 2012 plan), and 277 shares were issued at Rs. 10 per share (under the amended 2012 plan). Total amount realized by the company is Rs. 12,970. Following this allotment, the company's total paid-up equity share capital stands at Rs. 22.28 crore, comprising 2,22,82,238 equity shares of Rs. 10 face value each.
The dilution from this ESOP allotment is negligible (577 shares against a total of over 2.22 crore shares), so there is no meaningful impact on existing shareholders or the stock price. This is a routine employee stock option exercise disclosure.